Nicholas Investment Partners, LP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 142 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.5%.

Quarter-by-quarter ownership
Nicholas Investment Partners, LP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2019$10,089,000
+69.3%
106,956
+43.7%
0.92%
+73.9%
Q1 2019$5,960,000
+56.1%
74,451
+52.2%
0.53%
+73.9%
Q3 2018$3,819,000
+21.9%
48,921
-0.9%
0.31%
+39.1%
Q2 2018$3,133,000
-1.1%
49,362
+42.8%
0.22%
-3.1%
Q1 2018$3,169,000
-44.3%
34,556
-54.2%
0.23%
+20.7%
Q4 2017$5,694,000
+118.6%
75,510
+101.9%
0.19%
+4.4%
Q3 2017$2,605,000
+37.6%
37,394
+0.2%
0.18%
+34.3%
Q2 2017$1,893,000
+115.6%
37,337
+69.7%
0.13%
+116.1%
Q1 2017$878,00021,9980.06%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2017
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders